(Q34020982)

English

Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

30 July 2017

Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial (English)

1 reference

Europe PubMed Central

30 July 2017

multicenter clinical trial

0 references

0 references

Charles-Edouard Luyt

2

object named as

Charles-Edouard Luyt

0 references

Christian Brun-Buisson

14

object named as

Christian Brun-Buisson

1 reference

Europe PubMed Central

30 July 2017

author name string

Lila Bouadma

1

1 reference

Europe PubMed Central

30 July 2017

Florence Tubach

3

1 reference

Europe PubMed Central

30 July 2017

Christophe Cracco

4

1 reference

Europe PubMed Central

30 July 2017

Antonio Alvarez

5

1 reference

Europe PubMed Central

30 July 2017

Carole Schwebel

6

1 reference

Europe PubMed Central

30 July 2017

Frédérique Schortgen

7

1 reference

Europe PubMed Central

30 July 2017

Sigismond Lasocki

8

1 reference

Europe PubMed Central

30 July 2017

Benoît Veber

9

1 reference

Europe PubMed Central

30 July 2017

Monique Dehoux

10

1 reference

Europe PubMed Central

30 July 2017

Maguy Bernard

11

1 reference

Europe PubMed Central

30 July 2017

Blandine Pasquet

12

1 reference

Europe PubMed Central

30 July 2017

Bernard Régnier

13

1 reference

Europe PubMed Central

30 July 2017

Jean Chastre

15

1 reference

Europe PubMed Central

30 July 2017

Michel Wolff

16

1 reference

Europe PubMed Central

30 July 2017

PRORATA trial group

17

1 reference

Europe PubMed Central

30 July 2017

language of work or name

0 references

publication date

25 January 2010

1 reference

Europe PubMed Central

30 July 2017

1 reference

Europe PubMed Central

30 July 2017

375

1 reference

Europe PubMed Central

30 July 2017

9713

1 reference

Europe PubMed Central

30 July 2017

463-474

1 reference

Europe PubMed Central

30 July 2017

Antibiotic resistance in the intensive care unit

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961879-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Antibiotic susceptibility among aerobic gram-negative bacilli in intensive care units in 5 European countries. French and Portuguese ICU Study Groups

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961879-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Antibiotic resistance among gram-negative bacilli in US intensive care units: implications for fluoroquinolone use.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961879-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Strategies to Prevent and Control the Emergence and Spread of Antimicrobial-Resistant Microorganisms in Hospitals. A challenge to hospital leadership

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961879-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961879-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia. A randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961879-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Acinetobacter infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961879-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961879-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961879-1

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized controlled trial of an antibiotic discontinuation policy for clinically suspected ventilator-associated pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961879-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961879-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961879-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961879-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961879-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Procalcitonin-Guided Antibiotic Use vs a Standard Approach for Acute Respiratory Tract Infections in Primary Care

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961879-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Procalcitonin Guidance of Antibiotic Therapy in Community-acquired Pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961879-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961879-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961879-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961879-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961879-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961879-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961879-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The ACCP-SCCM consensus conference on sepsis and organ failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961879-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961879-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Current epidemiology of septic shock: the CUB-Réa Network.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961879-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Issues in noninferiority trials: the evidence in community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961879-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Longitudinal data analysis for discrete and continuous outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961879-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961879-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Procalcitonin for reduced antibiotic exposure in ventilator-associated pneumonia: a randomised study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961879-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961879-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961879-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Guidelines for the management of hospital-acquired pneumonia in the UK: report of the working party on hospital-acquired pneumonia of the British Society for Antimicrobial Chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961879-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Comprehensive evidence-based clinical practice guidelines for ventilator-associated pneumonia: diagnosis and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961879-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961879-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Procalcitonin kinetics as a prognostic marker of ventilator-associated pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961879-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Usefulness of procalcitonin for the diagnosis of ventilator-associated pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961879-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Emergence of resistance in normal human aerobic commensal flora during telithromycin and amoxicillin-clavulanic acid treatments

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961879-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961879-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Inadequate treatment of ventilator-associated pneumonia: risk factors and impact on outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961879-1

7 January 2021

based on heuristic

inferred from DOI database lookup

PNEUMOCOCCAL BACTEREMIA WITH ESPECIAL REFERENCE TO BACTEREMIC PNEUMOCOCCAL PNEUMONIA

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961879-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Daily cost of antimicrobial therapy in patients with Intensive Care Unit-acquired, laboratory-confirmed bloodstream infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961879-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(09)61879-1

1 reference

Europe PubMed Central

30 July 2017

1 reference

Europe PubMed Central

30 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34020982&oldid=1537629868"